ArticleJACC. Advances2023

Oral Anticoagulation for Atrial Fibrillation After TAVR: Is Vitamin K Antagonist Still the Primary Option?

Eric Van Belle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.